Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • General Inquiries
  • Worldwide Offices
  • Request More Information
  • Journalists

BOTTICELLI, THE INQUIETUDE AND THE BEAUTY - Menarini presents in Florence its latest art monograph, dedicated to the symbol of the Italian Renaissance
  • Brazil - Português
  • Latin America - español
  • USA - Deutsch
  • USA - español
  • USA - Français
  • USA - English
  • Italia - Italiano

MENARINI Group Logo

News provided by

Menarini Industrie Farmaceutiche Riunite

15 May, 2023, 13:44 IST

Share this article

Share toX

Share this article

Share toX

FLORENCE, Italy, May 15, 2023 /PRNewswire/ -- Successful artist, sensitive interpreter of the culture of his time and author of extraordinarily relevant works, Sandro Botticelli was a master of beauty.  With his "Venuses," he unknowingly established a canon of perfection that closely reflects that of modern day.  Yet, he was a mysterious and disquieted figure: despite his timeless reputation, his paintings still hide mysteries that are difficult to unveil.  After sixty years, Sandro Botticelli returns to the Menarini Group art series with an unpublished monograph presented in Florence at the Apollo Room in Palazzo Pucci in the presence of author Cristina Acidini, former superintendent of the art museums of Florence and today, president of the Opera di Santa Croce and other prestigious Florentine institutions.

Continue Reading
Nicola Armentano (City of Florence Councillor), Lucia Aleotti (Menarini Group Shareholder and Board Member), Cristina Acidini (Author of the Botticelli art monograph), Eric Cornut (Menarini Group Chairman), Eugenio Giani (President of Region of Tuscany); Elcin Barker Ergun (Menarini Group CEO), Alberto Giovanni Aleotti (Menarini Group Shareholder and Board Member) and Carlo Colombini (Menarini Group Board Member)
Nicola Armentano (City of Florence Councillor), Lucia Aleotti (Menarini Group Shareholder and Board Member), Cristina Acidini (Author of the Botticelli art monograph), Eric Cornut (Menarini Group Chairman), Eugenio Giani (President of Region of Tuscany); Elcin Barker Ergun (Menarini Group CEO), Alberto Giovanni Aleotti (Menarini Group Shareholder and Board Member) and Carlo Colombini (Menarini Group Board Member)
Presentation of the Menarini art volume dedicated to Botticelli
Presentation of the Menarini art volume dedicated to Botticelli

The monograph takes us back to Florence in the second half of the fifteenth century, to the dyeing plant of Mariano Filipepi, Botticelli's father. It was there that the young Sandro, fascinated by the colours used in the family's workshop, first came into contact with the study of the arts.  The few available sources who knew him presented the artist as a man inclined to irony, sarcasm and mockery, in the full Florentine spirit of the time.  His soul was tormented by a restless temperament; he categorically refused to marry but declared an eternal love for Florence, a city he never abandoned, with the exception of a few short trips.  With the acute sensitivity of human being and artist, he recorded the changes happening in his city, from the carnivalesque triumphs of Lorenzo de' Medici to the penitential processions of Savonarola.  As an artist, he had the unique ability to adapt to the changes of his era, painting tormented figures with darker colours, such as the Lamentation over the Dead Christ and the Holy Trinity (Pala delle Convertite), a far cry from the harmony and grace of the Birth of Venus and Primavera (Spring).  These two latter works, with their innumerable variations and reinventions, helped render Botticelli an extremely popular artist whose relevance resonates as a subject of modern study even today.

Thus, there are many controversies regarding the chronology and interpretation of many of Botticelli's paintings, including the most famous ones.  In fact, restorations and sophisticated diagnostic investigations constantly bring new elements to the surface which generate ideas for debate among specialists in the sector.

"This extraordinary artist returns to the Menarini series with a second monograph which takes into account the innovations that have emerged over the past sixty years, thanks to the discovery of new documents and their interpretations, especially regarding his most evocative and mysterious paintings.  Furthermore, the scientific investigations coinciding with the restoration of many of Botticelli's works have enriched our knowledge of his refined and versatile painting style," declared Cristina Acidini.  "Botticelli was, in fact, among the most authentic interpreters of the culture of his era, reflecting the profound changes in the Florentine society where he lived, dominated first by Lorenzo the Magnificent in a period of happy cultural flourishing, then by Girolamo Savonarola during years of disturbed religious reformism.  For this reason, he has become the "symbol" of the Renaissance, with all its splendour and its inquietude."

The art volume on Botticelli enriches Menarini Group's prestigious art series, created in 1956 to celebrate the beauty of Italy through the great masters of Italian painting.

"The Menarini art collection aims to promote great Italian artists and share them with even the youngest generation," say Lucia and Alberto Giovanni Aleotti, shareholders and members of the Board of Menarini.  "Discovering the inquietude and the wonder behind Botticelli's most notable paintings demonstrates how very close the artist was to today's contemporary sentiment."

Over the years, the artistic vocation of the Menarini Group has grown and evolved with the multimedia project 'Menarini Pills of Art'. These are short video clips in which experts reveal anecdotes and curiosities about many of the works featured in the Menarini volumes.  Around 700 videos have been published so far, for a total of tens of millions of views. These are available on the Menarini YouTube channel in 8 languages which is updated monthly with new content. Videos on some of Botticelli's most famous works have recently been published together with videos on Leonardo's Adoration of the Magi, Mantegna's Madonna delle Cave and Caravaggio's Bacchus.

The Menarini Pills of Art are available at the link: https://www.menarini.com/it-it/news/menarini-pills-of-art

The Menarini Pharmaceutical Group, with headquarters in Florence, is present in 140 countries worldwide to date, with €4,155 million in turnover and more than 17,000 employees. With 9 centres for Research & Development, Menarini's products are present in the most important treatment areas, including those of cardiology, oncology, gastroenterology, pneumology, infectious diseases, diabetes, and anti-inflammatory/analgesic products. Pharmaceutical production is carried out in the Group's 18 manufacturing plants, located in Italy and abroad, which produce over 577 million packets of product a year and distribute them to five continents. Menarini's pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients throughout the world. For further information please visit www.menarini.com

Photo - https://mma.prnewswire.com/media/2076875/Menarini_group.jpg
Photo - https://mma.prnewswire.com/media/2076874/Menarini_presentation.jpg
Logo - https://mma.prnewswire.com/media/1958938/4035543/MENARINI_GROUP_Logo.jpg

Modal title

Also from this source

Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition

Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition

The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a...

The Volpi Rosse Menarini: The 'Fantastic Ten' are ready for the 2025 - 2026 Season

The Volpi Rosse Menarini: The 'Fantastic Ten' are ready for the 2025 - 2026 Season

Ten international talents, differing in both age and experience but united by the desire to make a difference, both in Italy and Europe. After the...

More Releases From This Source

Explore

Art

Art

Entertainment

Entertainment

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.